Medical Research

Time marches on predictably, but biological aging is anything but constant, according to a new Stanford Medicine study.

Genomics and technology development expert Lars Steinmetz now leads Stanford Medicine’s genetics department.

Balls of intestinal cells from people with celiac disease faithfully model the disorder in a Stanford Medicine study. The lab-grown organoids revealed a new link between gluten and cell death.

A new study reveals social factors that increase the risk of dying from air pollution and finds stark racial disparities.

Animal model expert and genetics researcher Megan Albertelli, DVM, PhD, now heads Stanford School of Medicine department that contrasts human and animal health.

In an early Stanford Medicine study, CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy’s molecular target improved response.

Making a prognosis for spinal cord injury has been a guessing game, but a neuroimaging study by Stanford Medicine scientists and collaborators finds answers hiding in plain sight.

In a Stanford Medicine-led study, researchers combed through billions of compounds to find one that could enhance naloxone’s ability to fend off more potent opioids, with promising results in mice.

In an analysis of more than 2 million patient records, researchers discovered that people taking angiotensin receptor blockers for high blood pressure were less likely to develop epilepsy.

Brain imaging, known as functional MRI, combined with machine learning can predict a treatment response based on one’s depression “biotype.”…

In April, the FDA warned of risk of secondary cancers in people receiving CAR-T cell therapy. A large Stanford Medicine study finds the risk is low and not related to the CAR-T cells.